Stock Price

TSLX prices a $300M bond offering and plans a strategic swap to manage risk, signaling confidence and enhancing its firepower in private credit.

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

With key clinical data on the horizon for its cancer and ALS drugs, LeonaBio adds deep financial, operational, and strategic expertise to its leadership.

Bill Ackman's ambitious Pershing Square USA fund saw a rocky NYSE launch, even as it drew high-profile global investors like Mexico's Jack Landsmanas.

While the broader housing market cools, Las Vegas's exclusive golf communities maintain their value. A new report offers a glimpse inside this resilient niche.

Singaporean engineering firm SKK Holdings pivots dramatically, acquiring Rantizo's drone assets to chase growth in agriculture and emergency response tech.

Facing steep losses, FG Nexus is exploring a merger with its CEO's other firm, a move into affordable housing that tests both strategy and shareholder trust.

As Sachem Capital sets its Q1 earnings date, investors watch closely for signs of stability in the hard money lending market after a volatile period.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.

GreenTree Hospitality's Q4 results show a 25% revenue drop but a surprising 9.2% rise in core net income, signaling tough cost cuts and a cautious 2026.

The regional bank posted record earnings and boosted its dividend, defying market headwinds with exceptional efficiency and a surge in core customer deposits.

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.

With over $100B in institutional cash flooding Bitcoin, Bitcoin Magazine is launching a daily TV show for a new class of Wall Street allocator.

SCHMID Group reaffirms its ambitious 2026 forecast despite a slow start, banking on China's momentum and a major debt-for-equity conversion.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

PFIS declares a Q2 dividend increase, rewarding shareholders and showcasing stability amid mixed economic signals. What does this mean for investors and the community?

A 430% stock surge wasn't enough to save Leonardo's CEO from political ouster, sparking a battle between an activist investor and the Italian state.

Valley National Bancorp's Q1 results reveal a resilient path forward, driven by strategic deposit growth, improved credit quality, and early AI investment.

Community Health Systems is using cash to buy back $600M in debt. Is this a sign of strength or a defensive play in a turbulent healthcare market?